Transdermal Nicotine Patch 21mg/Day
Texto original en francés.
Producto de salud natural autorizado en Canadá
- Titular
- Dr. Reddy's Laboratories Canada Inc.
- NPN o DIN-HM
- 02241228
- Estado
- Licencia activa
- Fecha de licencia
- 3 de diciembre de 2007
- Fecha de revisión
- 7 de mayo de 2025
- Forma
- Timbre transdermique
- Vía de administración
- Transdermique
- Tipo de solicitud
- DIN de transition
El análisis de dosis orales no se aplica sin una vía exclusivamente oral establecida.
Composición
Composición medicinal no indicada.
Ingredientes no medicinales
Capric triglycéride, Acrylate vinylacetate copolymères, Aluminum, Metharylic acid esters copolymer, Paper
Dosis recomendadas en Canadá
| Población | Edad | Cantidad por toma | Frecuencia |
|---|---|---|---|
| Adultes | Non précisée | 1 patch | Non précisée |
Usos autorizados en Canadá
Transdermal nicotine patch is indicated as a temporary aid used to facilitate smoking cessation in smokers who strongly desire to give up their smoking habit.
Texto original en francés.
Un uso autorizado en Canadá no es una declaración de propiedades saludables autorizada en la Unión Europea. Consulte el registro de declaraciones de propiedades saludables.
Advertencias en Canadá
Cautions and Warnings : Consult your doctor before using this product if you have or have had heart, stroke, thyroid, circulation or stomach problems, stomach ulcers, mouth or throat inflammation, seizures, high blood pressure, circulation disorders of the brain, kidney or liver disease or if you are taking insulin or any prescription medicine. Do not use transdermal nicotine patch for more than 8 weeks without consulting a doctor. Do not smoke, chew nicotine gum, or use any other form of tobacco product while using transdermal nicotine patch.
Texto original en inglés.
Known Adverse Reactions : You may experience headache, sleep disturbances including insomnia and abnormal dreams, feeling sick, dizziness, anxiety, irritability, trembling, shortness of breath, cough, sore or swollen throat, fatigue, stomach upset (i.e. indigestion, stomach pains), diarrhea, and constipation, sweating, dry mouth, sensitivity of the skin to sunlight or joint, muscle, chest and limb pains. Some of these effects may be nicotine withdrawal symptoms or may be caused by nicotine. Remove the nicotine patch and consult your doctor if you experience irregular heart beat, chest pain, palpitations or leg pain occurs or if severe persistent stomach upset (indigestion, heartburn) develops. Signs and symptoms of nicotine overdose include severe headaches, dizziness, upset stomach, drooling, vomiting, diarrhea, cold sweats, blurred vision, difficulty in hearing, mental confusion, weakness, and fainting. If you experience any of these symptoms, remove the patch, flush the area with water only and tell your doctor immediately. It is normal to experience mild itching, burning or tingling when you first apply a patch, but this should disappear within an hour. After you remove a patch, the skin underneath may be somewhat red, but it should not stay that way for more than 2 days. If the skin under the patch becomes swollen or very red, or if you develop a rash, sudden wheeziness, tightness of the chest or feel faint remove the patch and call your doctor.
Texto original en inglés.
Contra-Indications : Do not use transdermal nicotine patch if you: Are a non-smoker or occasional smoker - are under 18 years of age - have a generalized skin disorder - have had a heart attack or stroke in the past 3 months, worsening angina or heart arrhythmias - are pregnant or breast-feeding; Avoid becoming pregnant while using nicotine patches. If you think you are pregnant remove the nicotine patch and see your doctor. - are allergic to nicotine, adhesive tape, bandages, or other components of the transdermal nicotine patch.
Texto original en inglés.
Fuente
Ficha oficial de Health Canada, licencia 02241228
Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias, consultado el 27 de octubre de 2026.
Contient des informations visées par la Licence du gouvernement ouvert – Canada (Santé Canada, BDPSNH)
Texto original en francés.
Texto original en francés.
La fórmula vendida en Europa con el mismo nombre puede ser diferente. Esta información no sustituye el consejo de un médico o farmacéutico.
Lista en la revisión oficial del (registro: Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias).
¿Ha cambiado el producto? Fotografíe el envase.